Skip to content

ThreatMate

MSP-focused platform combining attack surface discovery, automated penetration testing, and CISA-aligned configuration auditing into one risk-identification tool.

Visit Website ↗ + Add to Compare
45/100Emerging / Unranked

Overview

ThreatMate is a risk-identification platform built specifically for managed service providers (MSPs), combining attack surface discovery, vulnerability scanning, automated penetration testing, and configuration auditing into one tool. The pitch is that MSPs serving small and mid-sized clients need to prove exploitable risk to those clients in concrete terms rather than handing over a generic vulnerability scan report, so ThreatMate emphasizes documented, demonstrable evidence of exposure over theoretical CVE lists.

Founded in 2021, ThreatMate’s platform links directly into a client’s Microsoft 365 and Google Workspace tenants for attack surface discovery, runs CISA-aligned configuration baseline checks, and layers in user-exposure and dark-web-monitoring features alongside a prioritized remediation roadmap it calls a mission plan. This bundling of ASM, vulnerability management, and automated pentesting in one MSP-oriented tool is a reasonably distinct packaging choice, since most competitors in this space specialize in just one of those functions.

Public information about ThreatMate’s operations is limited: its registered address is in Dover, Delaware, funding details are not broadly disclosed, and no named enterprise or MSP customers, case studies, or independent third-party validation of its automated-pentesting or scanning accuracy were found during research. The company’s differentiation claims should be treated as plausible but largely unverified pending more public evidence.

Innovation Matrix Assessment

Innovation Velocity 5/10

Has built out attack surface discovery, automated pentesting, M365/Google tenant scanning, and CISA-aligned baselines within a few years of founding, a reasonably broad feature build-out for an early-stage vendor.

Operational Value 5/10

Bundles discovery, vulnerability scanning, automated penetration testing, and dark-web monitoring into one MSP-facing platform, functionally broad though unproven at scale in public sources.

Market Momentum 3/10

No major funding round, customer-count disclosure, or significant press coverage of growth was found; public momentum signals are limited relative to most other companies in this batch.

Category Disruption 5/10

Packaging attack surface management, automated pentesting, and compliance baselines specifically for the MSP channel, rather than selling each function separately, is a reasonably distinct go-to-market approach.

Real-World Efficacy 3/10

No named MSP or enterprise customers, case studies, or independent third-party validation of scanning or automated-pentest accuracy were found; efficacy evidence is limited to the vendor's own site.

Enduring Relevance 6/10

MSPs serving SMBs are a large and growing channel with a genuine need for continuous, demonstrable attack surface visibility to justify security spend to their end clients.

Why CISOs Should Care

Most directly relevant to MSPs needing to demonstrate concrete, exploitable risk to SMB clients rather than to enterprise CISOs managing security in-house.

What Makes It Different

Combines attack surface discovery, automated penetration testing, and CISA-aligned configuration baselines in a single MSP-oriented platform, rather than requiring MSPs to stitch together separate ASM, VM, and pentest tools.

The Matrix Verdict

45/100 — EMERGING / UNRANKED

A reasonably well-conceived MSP-focused ASM and automated-pentest bundle, but with thin public evidence of customer traction or independent validation; promising positioning that has not yet been substantiated by outside sources.

Editorial Note: Claims vs. Verified Findings

Feature descriptions (M365/Google tenant discovery, CISA-aligned baselines, automated pentesting) are drawn from ThreatMate's own website and were not independently verified. No independent customer references, funding disclosures, or third-party accuracy testing were found during research; all effectiveness claims here should be read as unverified vendor description.

Sources